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Abstract
Dysregulation of RNA metabolism represents an important pathogenetic mechanism in both amyotrophic lateral
sclerosis (ALS) and frontotemporal dementia (FTD) due to the involvement of the DNA/RNA-binding proteins TDP-43
and FUS and, more recently, of C9ORF72. A potential link between dysregulation of RNA metabolism and mitochondrial
dysfunction is recently emerged in TDP-43 disease models. To further investigate the possible relationship between these
two pathogenetic mechanisms in ALS/FTD, we studied mitochondria functionality in human mutant TARDBP(p.A382T)
and C9ORF72 fibroblasts grown in galactose medium to induce a switch from a glycolytic to an oxidative metabolism. In
this condition we observed significant changes in mitochondria morphology and ultrastructure in both mutant cells
with a fragmented mitochondria network particularly evident in TARDBP(p.A382T) fibroblasts. From analysis of the
mitochondrial functionality, a decrease of mitochondria membrane potential with no alterations in oxygen
consumption rate emerged in TARDBP fibroblasts. Conversely, an increased oxygen consumption and mitochondria
hyperpolarization were observed in C9ORF72 fibroblasts in association to increased ROS and ATP content. We found
evidence of autophagy/mitophagy in dynamic equilibrium with the biogenesis of novel mitochondria, particularly in
mutant C9ORF72 fibroblasts where an increase of mitochondrial DNA content and mass, and of PGC1-α protein was
observed. Our imaging and biochemical data show that wild-type and mutant TDP-43 proteins do not localize at
mitochondria so that the molecular mechanisms responsible for such mitochondria impairment remain to be further
elucidated. For the first time our findings assess a link between C9ORF72 and mitochondria dysfunction and indicate
that mitochondria functionality is affected in TARDBP and C9ORF72 fibroblasts with gene-specific features in oxidative
conditions. As in neuronal metabolism mitochondria are actively used for ATP production, we speculate that TARDBP
and C9ORF72 mutations might trigger cell death by impairing not only RNA metabolism, but also mitochondria activity
in ALS/FTD neurons.
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Introduction
Abnormal aggregates of TDP-43 protein represent a
neuropathological hallmark of the fatal motoneuron dis-
ease amyotrophic lateral sclerosis (ALS) and of fronto-
temporal dementia (FTD). TDP-43 forms pathological
cytoplasmic inclusions in affected brain tissues of nearly
all sporadic and familial ALS cases, with the exception of
SOD1-associated forms, and of a subset of patients with
FTD (FTD-TDP), representing an important molecular
link between these two apparently different neurodegener-
ative disorders [29]. TDP-43 is a DNA/RNA binding
protein, mainly localized in the nucleus where it is in-
volved in regulating splicing, transcription and miRNA
biogenesis, but it has also regulatory functions in the
cytoplasm controlling target mRNA stability, transport
and translation [26]. The presence of abnormal TDP-43
aggregates in the cytoplasm together with the concur-
rent depletion of TDP-43 from the nucleus suggest that
TDP-43 may trigger neuronal death by two different
pathogenetic mechanisms including a toxic gain-of-
function and/or a loss-of-nuclear function. Independ-
ently of the pathogenetic mechanism of TDP-43, RNA
metabolism is strongly impaired at different levels in
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both ALS and FTD, as further supported by the in-
volvement of another DNA/RNA binding protein, FUS,
in the pathogenesis of these two diseases [19, 22, 36].
The more recent identification of an intronic hexanu-
cleotide repeat expansion in C9ORF72 gene as the major
genetic cause of ALS and FTD has reinforced the molecu-
lar link between these two diseases and the role of RNA
metabolism dysfunction in their pathogenesis [14, 28, 31].
The expanded C9ORF72 transcripts, in fact, form patho-
logical RNA foci which sequester several RNA-binding
proteins and splicing factors in the nucleus, thereby glo-
bally affecting RNA processing and metabolism [15].
Mitochondrial dysfunction has long been associated
with neurodegenerative diseases, including ALS, where
defects in mitochondrial morphology and bioenergetics
have been largely described in muscle and brain tissues
from sporadic patients [1, 6, 13, 32, 33]. Moreover,
changes in bioenergetics properties were recently shown
in fibroblasts from sporadic ALS patients [4, 18] as well
as in fibroblasts from ALS patients carrying mutations
in SOD1 and VCP1 genes [5, 8]. In the case of SOD1,
alterations of mitochondria functionality are directly
triggered by the mutant SOD1 protein which induces
mitochondrial damage [5].
Recent literature data suggest a potential link between
mitochondrial dysfunction and defects in RNA metabolism
associated to TDP-43 protein. Mitochondria morphology,
dynamics and sub-cellular localization were described to be
altered in brain tissues of TDP-43 transgenic mice as well
as mitochondria functionality and transport into neurites
were defective in murine neuronal cells over-expressing
wild-type and mutant TDP-43 [16, 21, 34, 35, 38–40].
Localization of TDP-43 protein at mitochondria has been
suggested to have a direct effect on the functionality of
these organelles [16, 38].
To further assess the link between mitochondria and
RNA metabolism dysfunctions, we studied mitochondria
functionality in human fibroblasts of ALS and FTD pa-
tients carrying mutations in TARDBP and C9ORF72
genes. In contrast to experimental disease cell models
where mutant genes are over-expressed, patient-derived
fibroblasts allow to better investigate pathogenetic mecha-
nisms because mutant genes are expressed at physiological
levels. As fibroblasts mainly rely on a glycolytic metabol-
ism, they were grown in galactose medium to switch them
to a mitochondrial oxidative metabolism for ATP produc-
tion, similarly to neuronal cells.
Materials and methods
Human primary fibroblast cultures and SK-N-BE cell line
Fibroblasts were obtained from skin biopsies of 7 ALS/FTD
patients carrying mutations in TARDBP (p.A382T, n = 3)
and C9ORF72 (n = 4) genes after informed consent and in
accordance with guidelines approved by the local ethics
committee (IRCCS Istituto Auxologico Italiano Review
Board). Mutation analysis of TARDBP and C9ORF72 genes
was performed as previously described [12, 27]. Quantifica-
tion of C9ORF72 repeat expansions was obtained as re-
ported by Akimoto et al. [3]. Clinical data are presented in
Additional file 1: Table S1. Fibroblasts from 4 healthy indi-
viduals, age- and sex-matched with ALS/FTD cases, were
obtained as described above (n = 2) and from Telethon Bio-
bank (n = 2).
Fibroblasts were routinely maintained and expanded
in RPMI 1640 (EuroClone, Pero, Italy) containing 2 g/l
glucose and supplemented with 10 % fetal bovine serum
(FBS, Sigma Aldrich, St. Louis, MO), 2 mM L-glutamine,
2,5 μg/ml amphotericin B (Sigma Aldrich), 100 units/ml
penicillin and 100 μg/ml streptomycin in humid incuba-
tors at 37 °C with 5 % CO2. Cells used in the experi-
ments were grown in adhesion and expanded for no
more than 10 passages. To induce mitochondria to pro-
duce ATP thorough oxidative phosphorylation, fibro-
blasts were switched to grow for 48 h in RPMI medium
deprived of glucose and containing galactose (4.5 g/l),
10 % FBS, 5 mM sodium pyruvate and 2 mM L-glutam-
ine. All assays described, otherwise indicated, were per-
formed in this galactose-containing medium condition.
The human neuroblastoma cell line SK-N-BE (ATCC,
Middlesex, UK) was routinely maintained in RPMI 1640
supplemented with 4 g/l glucose, 10 % FBS, 2 mM L-
glutamine, 1 mM sodium pyruvate, 100 units/ml penicil-
lin and 100 μg/ml streptomycin. All reagents, otherwise
indicated, were purchased from Gibco (Thermo Fisher
Scientific, Waltham, MA, USA).
Cell transfection
Fibroblasts were plated in 6-well culture plates with 12 mm
diameter round coverslips and transfected with 1,5 μg/well
of pDsRed2Mito vector (Clontech Laboratories, Mountain
View, CA, USA) using Lipofectamine 2000 (Life Technolo-
gies, Thermo Fisher Scientific) according to the manufac-
turer’s instructions. After 48-h transfection, cells were fixed
using 4 % paraformaldehyde in phosphate buffer saline
(PBS, pH 7.4) for 15 min at room temperature. Fixed cells
were used for mitochondria morphology analysis.
For mitochondria isolation, SK-N-BE cells plated in
10 mm-dishes (n = 10) were transfected with flagTDP-
43wt or flagTDP-43p.M337V constructs (kindly provided
by Dr. Wilfried Rossoll, Emory University School of
Medicine, Atlanta, GA, USA) using Lipofectamine 2000.
After 48- h transfection, cells were harvested for subse-
quent mitochondria sub-fractionation procedures.
Mitochondrial network analysis
To visualize mitochondrial network, primary fibroblast
cultures were incubated with 100 nM MitoTracker Red
CMXRos (Life Technologies) for 30 min at 37 °C and
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then fixed with a 2:1 solution of 4 % paraformaldehyde
in PBS/culture medium. Fluorescence images were ac-
quired on Axiovert 200 epifluorescence inverted micro-
scope (Zeiss, Oberkochen, Germany) and Shape Factor
(SF) analysis was carried out using MetaMorph® software
(Universal Imaging Corp., Downingtown, PA, USA). The
program assigns a numeric value from 0 (flattened ob-
ject) to 1 (perfect circle) to the mitochondrial morph-
ology of a single cell. Three SF interval values were
considered in our quantitative morphology analysis:
group I (0–0.3) for cells with a prevalent filamentous
mitochondria network; group II (0.3–0.6) for cells with a
mixed population of filamentous and round-shaped
mitochondria; group III (0.6–1) for cells with a preva-
lence of round-shaped mitochondria. A total of 40 cells
for each group were analyzed.
To measure Form Factor (FF) and Aspect Ratio (AR),
images of pDsRed2Mito-transfected cells were acquired
with the Eclipse Ti inverted confocal microscope (Nikon,
Chiyoda, Japan) and converted to a 8-bit grayscale
format for analysis with ImageJ software (https://imagej.-
nih.gov/ij/) using two plug-ins (Adaptative threshold and
isolatedpixelsremoval). Images were then converted to a
binary image and areas higher than 6 pixels were ana-
lyzed. For each area the software calculates the AR par-
ameter, defined as the ratio between the major and
minor axis of the ellipse equivalent to the mitochondria,
and the circularity used to obtain the FF value (1/circu-
larity). At least 30 cells/group were considered with an
average number of 80 analyzed areas/cell.
Transmission electron microscopy
Approximately 5X106 cells were washed with PBS three
times and incubated with the fixing solution (glutaralde-
hyde 3 % in PBS 0,1 M pH 7,4) for 45 min at 4 °C
protected from light. Cells were scraped and, after cen-
trifugation at 2000 rpm at 4 °C for 15 min to form a
buffy coat of cells, washed with PBS three times and
post-fixed with 1 % OsO4 in 0,1 M PBS for 1 h. Samples
were dehydrated through graded alcohols, infiltrated and
embedded in SPURR resin. Ultrathin sections (60 nm)
were cut with Ultrotome Nova LKB placed on copper
grids and contrasted with uranyl acetate and lead citrate.
Observations were performed using a ZEISS EM 109
transmission electron microscope.
Western blot analysis
Cells were homogenized in lysis buffer (150 mM NaCl,
20 mM Tris-HCl, pH 7.4, 1 % Triton X-100, protease in-
hibitor cocktail) and incubated for 15 min on ice. Protein
lysates (25 μg) were resolved on 4–20 % mini protean
TGX Gel (Bio-Rad, Hercules, CA, USA) and transferred
to nitrocellulose membrane. Immunoblots were per-
formed with anti-MFN1 (1:1000, #ab57602), p62 (1:1000,
#ab91526), p84 (1:500, #ab487) and PGC1-α (1:200, #ab
77210 (Abcam, Cambridge, UK), FIS1 (1:1000, #ALX-210-
1037, Enzo Life Sciences, New York, NY, USA), Tubulin
(1:4000, #T6199) and TOMM20 (1;500, #WH000980
4M1) (Sigma Aldrich), CASP9 (1:500, #9502), CASP3
(1:1000, #9662) and LC3 (1:1000, #2775) (Cell Signaling,
Danvers, MA, USA), and TDP-43 (1:500, #10782-2-AP,
Proteintech, Chicago, IL, USA) antibodies. The Clarity
Western ECL Substrate (Bio-Rad) was used for chemilu-
minescence detection. Densitometric analyses were per-
formed using QuantityOne software (Bio-Rad).
Mitochondrial membrane potential
Fibroblasts were incubated with 40 nM Tetramethylrho-
damine methyl ester perchlorate (TMRM; Sigma Aldrich)
in HBSS-Ca/Mg solution (HEPES-buffered solution with
1.26 mM Calcium and 0.9 mM Magnesium) for 40 min at
room temperature, protected from light. Labeling with the
fluorescent probe MitoTracker Red CMXRos (250 nM,
Life Technologies) was conducted for 30 min at 37 °C in
medium protected from light. Fibroblasts were harvested
with trypsin and washed twice with PBS. Cells were resus-
pended in FACS Flow solution (BD Biosciences, Franklin
Lakes, NJ, USA) and cellular fluorescence intensity was
measured using a four colours cytometer (FACSCalibur;
BD Biosciences). For each sample, 10,000 events were re-
corded and the median of fluorescence intensity was used
for the subsequent analyses with the CellQuest software
(BD Biosciences).
ATP assay
Cells were counted and 5000 cells/well were seeded in
96 white microwell plates (Thermo Fisher Scientific).
Cellular ATP was measured using the ATPlite assay kit
(PerkinElmer, Waltham, MA USA) according to the
manufacturer’s protocol and normalized for cell number.
The plate was read on the Fluoroskan Ascent FL Micro-
plate Luminometer (Thermo Fisher Scientific) in lumi-
nescence mode.
Oxygen consumption rate measurement
Oxygen consumption rate (OCR) was measured in ad-
herent fibroblasts grown in galactose medium with a
XF96 Extracellular Flux Analyzer (Seahorse Bioscience,
North Billerica, MA, USA). Each control and mutant
fibroblast cell line was seeded in a XF 96-well cell
culture microplate (Seahorse Bioscience) at a density of
15 - 20 × 103 cells/well in 200 μL of growth medium and
incubated for 24 h at 37 °C in 5 % CO2 atmosphere.
After replacing the growth medium with 180 μL of
bicarbonate-free DMEM pre-warmed at 37 °C, cells were
preincubated for 1 h before starting the assay procedure.
After baseline measurements of OCR (OCR-B), OCR was
measured after sequentially adding 1 μM oligomycin
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(OCR-O) and 2.1 μM carbonyl cyanide 4-trifluoromethoxy-
phenylhydrazone (FCCP) (OCR-F). The protocol was per-
formed as already described [17]. Data were expressed as
pmol of O2 per minute, normalized by cell number and
evaluated by the CyQUANT Cell proliferation kit (Life
Technologies). Fluorescence was measured by a microplate
luminometer (Victor, PerkinElmer) with excitation wave-
length at 485 ± 10 nm and emission detection wavelength
at 530 ± 12.5 nm.
Mitochondrial respiratory chain enzyme activity
Enzyme activities of respiratory chain complexes were
measured spectrophotometrically as described previously
[10]. All enzymatic activities were normalized for citrate
synthase activity and protein concentration was mea-
sured according to Lowry et al. [20].
ROS detection
For detection of mitochondrial ROS levels, fibroblasts were
incubated with 5 μM MitoSOXTM (Life Technologies) in
HBSS-Ca/Mg for 10 min at 37 °C. The fluorescence inten-
sity was determined by a FACSCalibur cytometer, as de-
scribed above for mitochondrial membrane potential. For
cellular ROS detection, the day before the experiment
20,000 cells/well were plated in 96-well white plates and in
parallel in a generic 96-well clear plate for cell counting.
After incubation with 2′,7′-dichlorodihydrofluorescein
(DCFH2) 100 μM for 30′ minutes at 37 °C in the dark, the
white plate was read on aVictor plate reader (PerkinElmer),
in fluorescent mode, by using appropriate filters (approxi-
mate fluorescence excitation and emission 492–495 nm/
517–527 nm). Fluorescence intensity was then normalized
for cell number.
Quantitative Real time PCR
Total RNA from fibroblasts was retro-transcribed after
DNaseI (Roche, Basel, Switzerland) treatment using
SuperScript II-RT (Life Technologies), oligo dT and ran-
dom primers. Oligonucleotide pairs for SQSTM1/p62
and MAP1LC3 genes were designed with Primer Express
3.0 software (Applied Biosystems, Thermo Fisher Scien-
tific) on exon boundaries for gene expression analyses
(for primer sequences see Additional file 1: Table S2).
Real time PCR was performed for 45 cycles with SYBR
Green PCR Master mix (Applied Biosystems) and proc-
essed on ABI Prism 7900HT (Applied Biosystems). Reac-
tions were run in triplicate for each sample and a
dissociation curve was generated at the end. Threshold
cycles (Ct) for each tested gene were normalized on the
housekeeping Rpl10a gene value (ΔCt) and every experi-
mental sample was referred to its control (ΔΔCt). Fold
change values were expressed as 2-ΔΔCt.
Mitochondrial DNA content
Total DNA was extracted from fibroblasts with the Wizard
Genomic DNA Purification Kit (Promega, Fitchburg, WI,
USA) according to the manufacturer’s protocol. About
20 ng of total DNA was used in real-time PCR to evaluate
the mitochondria-encoded NADH dehydrogenase 5 gene
(MT-ND5) (Additional file 1: Table S2 for Taqman primer
and probe sequences) using the genomic ribonuclease P
(RPP) for data normalization (TaqMan RNAse P Control
Reagent kit, Applied Biosystems).
Mitochondrial mass
For determination of mitochondrial mass, fibroblasts
were incubated with 75 nM Mitotracker green FM
(MTG; Life Technologies) in cell medium for 30 min at
37 °C, protected from light. Cells were then harvested
and processed with a FACSCalibur cytometer as de-
scribed above.
Cell viability assay
Fibroblasts were plated in 24-well dishes, in quadrupli-
cate for each patient’s line. To determine viable/non-vi-
able cells, both medium and adherent fibroblasts were
collected. After centrifugation at 2000 rpm for 5 min,
supernatant was discarded and pellet was resuspended
in 20 μl medium. Cells were diluted 1:2 with trypan
blue stain 0,4 % (Gibco) which labels only non-viable
cells and cell viability was calculated as the number of
viable cells divided by the total number of cells within a
Burker’s chamber.
Immunofluorescence
After labeling mitochondria with MitoTracker Red
CMXRos dye (see above), cells were fixed as described
above and permeabilized with 0.3 % Triton X-100 and
blocked with 10 % normal goat serum (NGS, Gibco).
Incubation with the primary antibody anti-TDP-43
(1:500, Proteintech) was performed in blocking solution
for 1.30 h at 37 °C. The fluorescent-tagged secondary
antibody Alexa Fluor 488 (1:500, Life Technologies) was
used for detection. As a negative control, primary anti-
body was replaced by NGS. Nuclei were stained with 4′
6-diamidino-2-phenylindole (DAPI) (Roche) and slides
were mounted with Fluorsave (Calbiochem, San Diego,
CA, USA). Confocal images were acquired with the
Eclipse Ti inverted microscope (Nikon).
Mitochondria sub-cellular fractionation
For mitochondria isolation 8 x 106 fibroblasts (grown for
48 h in galactose-containing medium) and 20 x 106 SK-
N-BE cells, transfected with wild-type or mutant
flagTDP-43 constructs, were pelleted at 600xg for 8 min
at 4 °C, washed twice with PBS and resuspended in 1
volume of 0,1X of the hypotonic solution IB (35 mM
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Tris-HCl pH 7,8; 25 mM NaCl; 52 mM MgCl2). Cells
were lysated mechanically with 20 passages through a
1 ml syringe insulin needle and 1/10 of the initial vol-
ume of packed cells of 10x IB Buffer was immediately
added to make the solution isotonic. The homogenized
cells were centrifuged at 1,600xg for 3 min at 4 °C and
the supernatant transferred into a fresh tube. The pellet
was resuspended, homogenized, isotonized and centri-
fuged again for twice as described above. The superna-
tants were added to the previous one, centrifuged at
1600xg for 3 min at 4 °C to eliminate nuclei and unbroken
cells and centrifuged again at 16,000xg for 1 min. The
resulting pellet, containing the mitochondria-enriched
fraction, was solubilized in 1X IB Buffer and centrifuged
at 16,060xg for 1 min, washed in homogenization solution
A (0,32 M sucrose, 1 mM EDTA, 10 mM Tris-HCl
pH 7,4) and one more time with MAITE buffer (25 mM
sucrose, 75 mM sorbitol, 100 mM KCl, 0,05 mM EDTA,
5 mM MgCl2, 10 mM Tris-HCl pH 7,4, 10 mM H3PO4
(adjusted pH 7,4 in Tris base 0,5 M). The final pellet was
resuspended in an appropriate volume of MAITE buffer.
Every step was performed on ice. Total cell lysates (25 μg)
and mitochondrial fractions (15 μg) were analyzed by
Western blot analysis, as described above.
Statistical analysis
Statistical analysis was conducted with PRISM software
(GraphPad) by using the one-way ANOVA with Dun-
nett’s multiple comparison post hoc test for multiple
groups analyses and the unpaired t-test for two-groups
analyses. For the Shape Factor analysis the chi-square
test was applied. For AR and FF quantitative analyses
the Kruskal-Wallis with Dunns post hoc test was ap-
plied. Statistical analysis of the Seahorse data was per-
formed using the two-way ANOVA with Bonferroni
post-tests.
Results
Mitochondrial morphology in mTDP-43 and mC9ORF72
fibroblasts
To evaluate mitochondrial functionality in fibroblasts of
ALS/FTD patients carrying pathogenic mutations in
TARDBP and C9ORF72 genes, we first analyzed mito-
chondria morphology and network organization as po-
tential indicators of their pathophysiology. As fibroblasts
have a mainly glycolytic metabolism, they were grown in
oxidative conditions in galactose-containing medium for
48 h to induce them to rely on oxidative phosphoryl-
ation (OX-PHOS) for energy production [30]. Primary
fibroblasts obtained from 3 ALS patients harboring the
same mutation (p.A382T) in TARDBP gene, 4 patients
with pathological expansion of the hexanucleotide repeat
sequence in C9ORF72 gene and 4 healthy controls
(Additional file 1: Table S1) were transfected with the
mitochondria-tagging plasmid pDsRed2Mito or live-
labeled with the Mitotracker Red dye. In these oxidative
conditions mutant TDP-43 (mTDP-43) fibroblasts showed
fragmentation of the mitochondria network compared to
control cells, with the prevalence of round-shaped mito-
chondria (Fig. 1a and Additional file 1: Figure S1). Mutant
C9ORF72 (mC9ORF72) fibroblasts showed a less evident
alteration of mitochondria network compared to mTDP-
43 cells, but mixed populations of elongated, short and
round-shaped mitochondria were frequently observed
within a single cell (Fig. 1a and Additional file 1: Figure S1).
In contrast, no morphological alterations of mitochondria
were observed in mutant fibroblasts maintained in
standard growing conditions with glucose as a main
carbon source (data not shown).
For the quantitative analysis of the mitochondrial net-
work changes observed in oxidative condition, we mea-
sured the Shape Factor (SF) parameter, an index of cell
mitochondria morphology and organization with values
ranging from 0 (cells with flattened mitochondria) to 1
(cells with circular mitochondria). Three main categories
were arbitrary chosen and cell distribution in the three
different classes (0-0.3; 0.3–0.6; 0.6–1) was evaluated for
each fibroblast group (Fig. 1b and Methods). The pattern
of cell distribution was significantly different in mTDP-
43 fibroblasts compared to controls. In particular, a
decreased number of cells in the first category (0–0.3)
and an increased amount of cells in the other two
categories was evident, indicating fragmentation of the
mitochondria network (Fig. 1b). No significant differ-
ences were detected in mC9ORF72 fibroblasts compared
to controls, although a slight increase of the intermedi-
ate class was observed (Fig. 1b).
A more detailed image analysis was performed on sin-
gle mitochondria area to measure other two quantitative
morphological parameters, such as Aspect Ratio (AR),
an indicator of mitochondria length, and Form Factor
(FF), reflecting both length and degree of mitochondria
branching. Both AR and FF values were significantly
lower in both mTDP-43 and mC9ORF72 fibroblasts
compared to healthy cells, although differences were
higher for mTDP-43 mitochondria (Fig. 1c). Quantitative
morphology analyses clearly suggest that mitochondria
network is altered in both mutant fibroblast groups, with
mTDP-43 cells presenting a more fragmented mitochon-
dria network compared to mC9ORF72.
In line with these results, electronic microscopy ana-
lysis indicated that, although both mutant fibroblasts
had a normal aspect considering the reticulum, mem-
branes and nuclei, they showed some mitochondria
alterations in all samples examined, namely lamellar dis-
tribution and paucity of cristae (Fig. 1d). Few autophagic
and mitophagic vacuoles were also present in both
mTDP-43 and mC9ORF72 cells (Fig. 1d).
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Fig. 1 Mitochondria morphology of mutant TARDBP and C9ORF72 fibroblasts after 48 h in galactose medium. a Representative confocal images of
mitochondrial network in fibroblasts from 4 controls (CTRL), 3 ALS patients with the TARDBP p.A382T mutation (mTDP-43) and 4 ALS/FTD patients with
mutations in C9ORF72 (mC9ORF72). Fibroblasts were transfected with pDsRed2Mito. Bar, 10 μm. b Quantitative analysis of mitochondrial network in
mTDP-43, mC9ORF72 and CTRL fibroblasts labelled with Mitotracker Red dye. Cell distribution in the three arbitrary chosen Shape Factor classes (0–0.3;
0.3–0.6; 0.6–1) was evaluated for each fibroblast group (mean ± SEM; Chi-square test; ***p< 0.001). c Quantitative analysis of mitochondrial network by
Aspect Ratio (AR), an indicator of mitochondria length, and Form Factor (FF), reflecting both length and degree of mitochondria branching, in mTDP-43,
mC9ORF72 and control fibroblasts transfected with pDsRed2Mito construct. Data are presented in dot plot graphs in logarithmic scale and median values
are presented (red bar); Kruskal-Wallis with Dunns post hoc test; ***p< 0.001. d Representative images of electron microscopy analysis of CTRL (panel 1),
mTDP-43 (panels 2-3) and mC9ORF72 (panel 4) fibroblasts. Paucity of cristae is indicated by an asterisk. A higher magnification of an unrelated mTDP-43
cell shows two degenerating mitochondria with lamellar distribution of cristae (panel 3, arrowhead). In mC9ORF72 fibroblasts a few autophagic vacuoles
(panel 4, pound key) degenerating mitochondria showing mitophagic alterations (arrow) and both lamellar distribution and paucity of cristae (arrowhead)
are present. Bar: 0.42 μm (panels 1,2,4); 0,1 μm (panel 3). e Representative WB analysis of MFN1 and FIS1 proteins in CTRL and mTDP-43 fibroblasts (upper
panel). Densitometric analyses of WB data are shown (mean ± SEM of 4 controls and 3 TARDBP p.A382T patients, unpaired t-test, **p< 0.01) (lower panel).
Lysates from 3 different DIV were considered for each cell line. f Representative WB (upper panel) and densitometric analyses (lower panel) of CTRL and
mC9ORF72 fibroblasts (mean ± SEM; n= 3 different DIV; unpaired t-test, **p< 0.01)
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Mitochondria dynamics was then investigated by asses-
sing the content of two factors involved in fission and
fusion processes, such as Fission 1 (FIS1) and Mitofusin 1
(MFN1) proteins, respectively. Western blot (WB) ana-
lyses indicated that FIS1 levels were significantly
increased in mTDP-43 fibroblasts (149 %) compared
to control cells (Fig. 1e), while MFN1 content was
increased specifically in mC9ORF72 cells (178 %)
(Fig. 1f ). These results suggest that an altered balance
of fission and fusion processes may account for the
mitochondria morphology changes observed in mT
DP-43 and mC9ORF72 fibroblasts.
Mitochondrial functionality of mTDP-43 and mC9ORF72
fibroblasts
To investigate the potential correlation between the
mitochondria morphological changes observed in both
mutant fibroblasts in oxidative state and their bioener-
getic efficiency, we measured mitochondrial membrane
potential (MMP) with TMRM dye by FACS analysis. We
observed a significant depolarization of mitochondria in
mTDP-43 fibroblasts, where the median MMP value was
approximately 80 % compared to control group, whereas
in mC9ORF72 fibroblasts the median MMP value signifi-
cantly increased to 129 %, indicating hyperpolarized mito-
chondria (Fig. 2a). These results were further confirmed by
measuring MMP with another MMP-dependent dye, the
MitoTracker Red CMXRos (Additional file 1: Figure S2).
No changes in MMP were instead detected when fibro-
blasts were grown in glycolytic conditions (Additional
file 1: Figure S3), reflecting the absence of morphological
alterations of mitochondria in the same conditions.
In line with the increase of MMP value in mC9ORF72
fibroblasts, a significant increase of ATP content was ob-
served, whereas no change of ATP levels was found in
mTDP-43 cells (Fig. 2b). To further characterize mito-
chondrial functionality in oxidative state, we evaluated
oxygen consumption rate (OCR) in control and mutant
fibroblasts in different conditions: 1) in basal conditions
(OCR-B); 2) when oxygen consumption was inhibited
by the ATP synthesis blocker oligomycin (OCR-O); 3)
when oxygen consumption was stimulated by the oxi-
dative phosphorylation uncoupler FCCP (OCR-F). We
observed that the overall oxygen consumption rate
was enhanced in mC9ORF72 fibroblasts, with both
OCR-O and OCR-F reaching statistically significant
increase as compared to both controls and mTDP-43
cells (Fig. 2c), indicating high activity of the electron
transport chain (ETC).
Since global mitochondria respiration emerged to be
altered specifically in mC9ORF72 fibroblasts, the bio-
chemical analysis of each single ETC complex activity
was performed. No significant differences were mea-
sured in both mutant fibroblasts compared to controls,
although for some complexes, we noticed a tendency to-
ward an increase (Fig. 2d and Additional file 1: Table S3).
We observed that succinate dehydrogenase (SDH) activity
was significantly higher in mC9ORF72 fibroblasts com-
pared to control cells and a trend toward an increase was
also present in mTDP-43 fibroblasts although it did not
reach statistical significance (Fig. 2d).
In order to investigate if the mitochondria bioenergetic
dysfunctions were associated with oxidative stress, we
next measured reactive oxygen species (ROS) levels in
mutant cells. In particular, we evaluated total cellular
ROS levels by DCFH2 reagent and, as the results of such
measurement may be influenced by other factors [9],
specific mitochondrial ROS levels were determined by
using mitoSOX. We found a consistent and significant
increase of mitochondrial ROS along with a parallel
increase of total cellular ROS levels specifically in
mC9ORF72 cells compared to both healthy control and
mTDP-43 fibroblasts (Fig. 2e-f ).
The mitochondria quality system in mTDP-43 and
mC9ORF72 fibroblasts
Given the alterations in mitochondrial morphology and
functionality observed in mTDP-43 and mC9ORF72 fi-
broblasts, we next investigated the processes associated
to removal of damaged mitochondria and/or biogenesis
of these organelles. Quantification of p62 and LC3 levels,
as markers of autophagic vesicle formation, showed a
significant decrease of p62 protein level both in mTDP-
43 (Fig. 3a) and in mC9ORF72 fibroblasts (Fig. 3b) (60
and 74 %, respectively) compared to control fibroblasts
with no change in SQSTM1/p62 gene expression level
(Fig. 3c). The ratio between lipidated/unlipidated LC3
proteins (LC3-II/LC3-I) and the total MAP1LC3B
mRNA content were not different between mutant fibro-
blasts and control cells (Figs. 3a-b-d). These results,
together with electronic microscopy data showing few
autophagic/mitophagic vacuoles in both mutant fibro-
blast groups (Fig. 1d), suggest an early activation of the
autophagic process.
As removal of damaged mitochondria is a dynamic
process in equilibrium with the biogenesis of novel
organelles, we measured the content of mitochondrial
DNA as a marker of mitochondrial biogenesis. The level
of mitochondria-encoded NADH dehydrogenase 5 (MT-
ND5) was slightly increased in mTDP-43 fibroblasts, but
significantly higher in mC9ORF72 fibroblasts as com-
pared to controls (Fig. 3e). Moreover, evaluation of PG
C1-α protein, a regulator of mitochondria biogenesis,
showed significantly increased levels only in mC9OR
F72 fibroblasts, while no changes in mTDP-43 fibro-
blasts were detected compared to controls (Fig. 3f ).
Differences in markers of mitochondria biogenesis in mu-
tant mC9ORF72 fibroblasts reflected also differences in
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mitochondria content. In fact, mitochondria mass (MM),
measured by Mitotracker GreenFM dye, significantly and
specifically increased in mC9ORF72 fibroblasts (172 %)
compared to control cells, whereas it significantly dimin-
ished in mTDP-43 cells (65 %) (Fig. 3g). No changes in
MM were observed in mutant fibroblasts grown in stand-
ard culture conditions in glucose-containing medium
(Additional file 1: Figure S4), further suggesting that mito-
chondria alterations become evident only when cells are
forced to switch from a glycolytic to an oxidative state.
Cell viability and apoptosis in mTDP-43 and mC9ORF72
fibroblasts
To evaluate if the observed alterations in autophagy and
mitochondria biogenesis may trigger cell death, we mea-
sured cell viability and we found no evidence of cell mor-
tality in both mTDP-43 and mC9ORF72 fibroblasts
compared to control cells (Fig. 4a). Evaluation of Caspase
9 and Caspase 3 by WB assay revealed no changes in their
protein pattern in both control and mutant fibroblasts in-
dicating no activation of the apoptotic pathway (Fig. 4b).
Fig. 2 Mitochondrial functionality of mutant TARDBP and C9ORF72 fibroblasts in galactose medium. a Measurement of mitochondrial membrane
potential (MMP) by flow cytometry analysis of TMRM-positive fibroblasts (4 healthy controls, 3 TARDBP p.A382T (mTDP-43) and 4 C9ORF72
(mC9ORF72). Median ± SEM, n = 3 different DIV; one-way ANOVA with Dunnett’s multiple comparison test, *p < 0.05; **p < 0.01. b Evaluation
of ATP content by the ATPlite kit. Mean ± SEM, n = 3 different DIV; one-way ANOVA with Dunnett’s multiple comparison test, **p < 0.01. c. Analysis of
oxygen consumption rate in basal condition (OCR-B), upon treatment with oligomycin (OCR-O) and with the oxidative phosphorylation uncoupler
FCCP (OCR-F). Data are presented as mean ± SEM; n = 5 different DIV; two-way ANOVA with Bonferroni post-tests; *p < 0.05 and **p < 0.01 vs. basal.
d Measurement of the respiratory electron transport system activity (complexes I-IV) and of succinate dehydrogenase (SDH) in 3 CTRL, 3 mTDP-43
and 4 mC9ORF72 fibroblasts. Values are expressed as nmol/min/mg protein and normalised with citrate synthase activity (mean ± SEM, one-way ANOVA
with Dunnett’s multiple comparison test; *p< 0.05). e Mitochondrial ROS detection by flow cytometry analysis after incubation with MitoSOX™ Red reagent.
Mean ± SEM; n = 3 different DIV; one-way ANOVA with Dunnett’s multiple comparison test; **p < 0.01. f Cellular ROS detection after
incubation with 2′,7′-dichlorodihydrofluorescein (DCF). Fluorescence intensity was normalized for cell number. Mean ± SEM; n = 3
different DIV; one-way ANOVA with Dunnett’s multiple comparison test; **p < 0.01
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Fig. 3 (See legend on next page.)
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Analysis of TDP-43 sub-cellular localization
Recent literature data on mouse motoneuronal cell lines
and primary neurons reported that both wild-type and
mutant TDP-43 proteins may localize at mitochondria
thereby directly affecting their functionality [16, 21, 38].
We investigated whether the endogenous wild-type and
mutant TDP-43 distributed at mitochondria also in hu-
man fibroblasts.
By immunofluorescence analysis we failed to detect
TDP-43 co-localization with mitochondria and TDP-43
mislocalization in the cytoplasm both in control and
mTDP-43 fibroblasts (Fig. 5a). Also in mC9ORF72 cells
no localization of TDP-43 at mitochondria was observed
(Additional file 1: Figure S5). By performing sub-cellular
fractionation assays in control and mTDP-43 fibroblasts,
both wild-type and mutant TDP-43 proteins were not
present in the mitochondria-enriched fractions, which
were positive for the mitochondria marker TOMM20
(Fig. 5b). Nuclear and cytoplasmic contamination of the
obtained mitochondria-enriched fractions was evaluated
by WB analysis with p84 and tubulin markers, respectively
(Fig. 5b). When we also over-expressed wild-type and
mutant TDP-43 p.M337V in human neuroblastoma SK-
N-BE cells, we did not recover either proteins in the
mitochondria-enriched fractions (Fig. 5c), in contrast to
what previously reported [16].
In addition, an in silico analysis of TDP-43 aminoacid
sequence by Mitoprot, PSORT, and TargetP algorithms
failed to recognize the presence of the consensus motif
for protein import into mitochondria.
Overall these data seem to suggest that the mitochon-
dria dysfunctions observed in mTDP-43 fibroblasts are
not likely to be directly associated with localization of
TDP-43 protein at mitochondria.
Discussion
In the present study we showed that mutations in TAR
DBP and C9ORF72 genes, associated to defects in RNA
(See figure on previous page.)
Fig. 3 Analysis of autophagy and mitochondria biogenesis in mutant TARDBP and C9ORF72 fibroblasts in galactose medium. a Representative
WB analysis of p62 and LC3II/I in lysates of control (CTRL) and mutated TARDBP (mTDP-43) fibroblasts (left panel). Tubulin was used for sample
normalization. Densitometric analyses of WB data are shown in the right panels; the ratio between lipidated (II) and unlipidated (I) protein is
shown for LC3 (mean ± SEM of 3 controls and 3 mTDP-43 patients; n = 3 different DIV; unpaired t-test, **p < 0.01). b Representative WB analysis
of p62 and LC3II/I in lysates of CTRL and mutated C9ORF72 (mC9ORF72) fibroblasts (left panel). Tubulin was used for sample normalization.
Densitometric analyses of WB data are shown in right panels (mean ± SEM of 3 controls and 4 mC9ORF72 patients, n= 3 different DIV; unpaired t-test,
*p< 0.05). Q-PCR analysis of c SQSTM1/p62 and d MAP1LC3 mRNA content in CTRL, mTDP-43 and mC9ORF72 fibroblasts. Fold change values were
calculated versus CTRL fibroblasts (mean ± SEM; n = 3 different DIV; one-way ANOVA with Dunnett’s multiple comparison test). e Quantification
of mitochondrial DNA content by Q-PCR of the mitochondria-encoded NADH dehydrogenase 5 (MT-ND5) gene. The genomic ribonuclease
P gene was used for data normalization (mean ± SEM; n = 3 for each experimental group; one-way ANOVA with Dunnett’s multiple comparison
test). f Representative WB analysis of PGC1α in lysates of controls (CTRL), mTDP-43 (left panel) and mC9ORF72 (right panel) fibroblasts. Tubulin
was used for sample normalization. Densitometric analyses of WB data are shown in the lower left and right panels (mean ± SEM; n = 3 different
DIV; unpaired t-test, *p < 0.05). g Measurement of mitochondrial mass (MM) by flow cytometry analysis of Mitotracker green (MTG)-positive
fibroblasts (4 healthy controls, 3 mTDP-43 and 4 mC9ORF72). Median ± SEM; n = 3 different DIV; one-way ANOVA with Dunnett’s multiple
comparison test; **p < 0.01
Fig. 4 Cell viability and apoptosis in mutant TARDBP and C9ORF72 fibroblasts in galactose medium. a Cell viability was assessed by trypan blue stain in
control (CTRL), mutated TARDBP p.A382T (mTDP-43) and C9ORF72 (mC9ORF72) fibroblasts. b WB analysis of caspase 9 (CASP9) and 3 (CASP3) in lysates of 4
CTRL, 3 mTDP-43 and 4 mC9ORF72 fibroblasts. Asterisk indicates the expected position of the cleaved forms of the two caspases. n= 3 different DIV
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metabolism in ALS and FTD neurodegenerative dis-
eases, affect mitochondria functionality by altering sev-
eral morphological and bioenergetics parameters in a
gene-specific manner. These alterations were detected in
peripheral disease cell models derived from patients,
such as mutant fibroblasts, when they were induced to
change their glycolytic metabolism and to actively use
oxidative phosphorylation for ATP production as neur-
onal cells.
In neurodegenerative disorders the study of pathome-
chanisms is hampered by the difficulty to monitor
disease progression in the affected brain tissues, and
autoptic tissues have the bias of representing the end-
stage state of the disease. Nonetheless, in Alzheimer’s
and Parkinson’s disorders, pathophysiological alterations
of the central nervous system were also similarly present
in patients’ peripheral tissues, such as blood and fibro-
blasts [7, 24]. Although fibroblasts have been scarcely
investigated in ALS disease so far [2, 23], they were re-
cently described to be defective in their bioenergetics me-
tabolism both in familial and sporadic ALS cases [5, 8, 18,
25]. In contrast to experimental disease cell models
where the mutant genes are usually over-expressed,
patient-derived fibroblasts have the advantage of
expressing mutant genes at physiological levels, there-
fore preventing any bias due to the aberrant over-
production of the protein of interest.
Our analysis of mitochondrial functionality in mTDP-
43 and mC9ORF72 fibroblasts revealed gene-specific
alterations in mitochondrial morphology and dynamics,
membrane potential, respiration and ATP production
specifically occurring in oxidative conditions. In fact,
these changes were absent when mutant fibroblasts were
grown in glycolytic conditions. We found alterations in
mitochondria morphology in both mTDP-43 and mC9O
RF72 fibroblasts, as indicated by significant changes in AR
Fig. 5 Analysis of TDP-43 sub-cellular localization in human fibroblasts and SKNBE cells. a Representative immunofluorescence images of TDP-43
(green) in primary fibroblasts from 4 healthy controls (CTRL) and 3 ALS patients carrying p.A382T mutation in TARDBP gene (mTDP-43), incubated with
Mitotracker Red (red). Bar, 10 μm. b WB analysis of TDP-43 and TOMM20 proteins in total cell lysates (TOT) and mitochondria-enriched fractions (MT) of
CTRL and mTDP-43 fibroblasts maintained in galactose medium for 48 h. p84 and tubulin (TUB) were used to test contamination with nuclear and
cytoplasmic fractions, respectively. c WB analysis of TDP-43 and TOMM20 proteins in total cell lysates (TOT) and mitochondria-enriched fractions (MT)
of SK-N-BE cells transfected for 48 h with flag-tagged wild-type (fTDP-43wt) and mutant p.M337V (fTDP-43p.M337V) TDP-43 constructs. Asterisk indicates
flag-tagged TDP-43 proteins. p84 and tubulin (TUB) were used as nuclear and cytoplasmic markers, respectively. Different protein amounts were loaded
for TOT (25 μg) and MT (15 μg) fractions
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and FF quantitative parameters and in mitochondrial ultra-
structure and density by electronic microscopy. In particu-
lar, a very fragmented mitochondria network was evident in
mTDP-43 fibroblasts in association to the up-regulation of
FIS1 protein content. An altered balance of fission and
fusion processes, also evidenced in mC9ORF72 fibroblasts
with increased MFN1 levels, may well account for the ob-
served mitochondria morphology changes. Interestingly,
the presence of altered mitochondria with paucity of cristae
was previously described in spinal cord of TDP-43 trans-
genic mice in association with an abnormal sub-cellular
distribution and trafficking of mitochondria and with dys-
regulation of proteins involved in fission and fusion pro-
cesses [34, 35, 38–40]. Also murine neuronal cell models
over-expressing wild-type or mutant human TDP-43
proteins were described to have alterations in mito-
chondria morphology, dynamics and transport along
neurites [16, 21, 38]. On the other hand, mitochondria
alterations have not been reported or investigated in
C9ORF72 cellular and animal models so far, but our
findings suggest that C9ORF72-mediated pathome-
chanisms, either through expanded RNA/dipeptide
protein gain-of-function or C9ORF72 protein haploin-
sufficiency, may also affect mitochondria metabolism.
Our data also suggest that mutant TARDBP and C9O
RF72 trigger mitochondria alterations in response to
energy demand in a specific manner because mitochon-
drial morphological changes were not present in mu-
tant SOD1 and sporadic ALS fibroblasts when they
were similarly exposed to oxidative conditions in
galactose-containing medium [4, 5].
In line with the evidence that mitochondria morph-
ology may reflect mitochondria functionality, we found
alterations in the mitochondria membrane potential,
which significantly changed in a different manner in
the two mutant fibroblasts. Mitochondria membrane
potential was specifically reduced in mTDP-43 fibro-
blasts and increased in mC9ORF72 cells. Mitochondria
depolarization was also described in murine TDP-43
cell models, but when both wild-type and mutant TDP-
43 were over-expressed in primary motor neurons or in
NSC-34 cells [16, 21, 38]. Human fibroblasts from spor-
adic ALS patients showed mitochondria hyperpolariza-
tion when they were grown in glycolytic conditions
[18]. Here we found that mutations in TARDBP and
C9ORF72 were associated to alterations of mitochon-
dria membrane potential only when cells had to rely
mainly on oxidative phosphorylation for ATP synthesis.
When we evaluated the mitochondria bioenergetics, we
observed an increase of oxygen consumption rate only
in mC9ORF72 fibroblasts after blocking ATP synthesis
and after uncoupling respiration, in association with
normal respiratory chain enzymatic activities but
increased SDH activity. A similar increase in oxygen
consumption was observed also in mutant SOD1 fibro-
blasts when they were exposed to galactose-containing
growing medium, although this was not associated with
mitochondria morphological alterations as in mC9O
RF72 cells [5]. The increased oxygen consumption rate
may reflect an efficient and tightly coupled ETC activity
in mC9ORF72 fibroblasts, thus accounting for the ob-
served higher ATP content, while the increased MMP
may favour electron slippage and trigger ROS produc-
tion as sustained by our experimental data.
Among the mitochondrial changes, we found also an
increase of mitochondrial DNA content and mass specif-
ically in mC9ORF72 fibroblasts, suggesting the presence
of compensatory proliferation mechanisms of aberrant
mitochondria, which could also explain the higher
oxygen consumption rate, ATP level and ROS produc-
tion in these cells. We speculate that the same mechan-
ism is probably not active in mTDP-43 fibroblasts which
showed depolarized mitochondria, but were not able to
activate mitochondrial proliferation to counteract mito-
chondrial dysfunctions. Since mitochondrial fission
usually precedes mitophagy [11, 37], the observed frag-
mentation of the mitochondrial network and the pres-
ence of autophagic/mitophagic vacuoles in mTDP43
fibroblasts seem to support this hypothesis. The autoph-
agic process is also partially activated in mC9ORF72 as
evidenced by electron microscopy data and p62 protein
down-regulation.
Whether a direct or an indirect effect of mTDP-43
and mC9ORF72 is responsible for the observed mito-
chondria dysfunctions still remains to be elucidated. Our
data suggest that in human fibroblasts both wild-type
and mutant TDP-43 proteins do not localize at mito-
chondria and therefore are not likely to influence
directly their functioning. Also in condition of TDP-43
over-expression in human neuronal cell lines, we did not
observe translocation of TDP-43 into mitochondria. On
the contrary, recent literature data supported the hy-
pothesis of a direct effect on mitochondria based mainly
on the presence of TDP-43 protein in mitochondria-
enriched fractions obtained by cell fractionation assays
[16, 38]. However, as contamination with nuclear
materials, and likely nuclear TDP-43, may not be com-
pletely excluded in these assays, this issue will need
further investigation.
Altogether our results indicate that mutations in
TARDBP and C9ORF72 genes may differentially affect
mitochondria activity and bioenergetics in ALS and FTD
patient-derived cells when they are induced to use oxida-
tive phosphorylation for ATP production. This further
supports the evidence of a link between defects in TDP-
43-mediated RNA metabolism and mitochondria
dysfunction [16, 21, 38]. However, as in this study we
considered ALS patients carrying the same TARDBP
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p.A382T mutation, which is the most frequent one in
the Italian population [12], also different TARDBP muta-
tions will worth investigation.
Conclusions
Our findings highlight for the first time that mutant
C9ORF72 impairs mitochondria activity in a different
and opposite manner compared to mutant TDP-43. We
speculate that TARDBP and C9ORF72 mutations might
trigger cell death by impairing not only RNA metabol-
ism, but also mitochondria activity in ALS/FTD neurons
since their mitochondrial energetic metabolism depends
mainly on oxidative phosphorylation. The use of neu-
rons/motoneurons differentiated from induced pluripo-
tent stem cells obtained from mTDP-43 and mC9ORF72
fibroblasts will certainly help to address and further in-
vestigate this important issue.
Additional file
Additional file 1: Figure S1. Mitochondria morphology in mutant
TARDBP and C9ORF72 fibroblasts after 48 h in galactose medium.
Representative confocal images of mitochondrial network in primary
fibroblasts from three healthy controls (C1, C2, C3), three ALS patients carrying
mutation in TARDBP gene (p.A382T; T1, T2, T3) and three ALS//FTD patients
with pathological expansion of the hexanucleotide repeat in C9ORF72 (C9.2,
C9.3, C9.4) transfected with pDsRed2Mito construct. Bar, 10μm. Figure S2.
Mitochondria functionality in mutant TARDBP and C9ORF72 fibroblasts.
Measurement of mitochondrial membrane potential by flow cytometry
analysis of Mitotracker Red (MTR) positive fibroblasts (from 4 healthy controls,
3 TARDBP and 4 C9ORF72 mutated patients) maintained in medium with
galactose and without glucose. Median ± SEM, n= 3 different DIV; One-way
ANOVA with Dunnett’s multiple comparison test; **p < 0.01). Figure S3.
Analysis of mitochondria membrane potential in mutant TARDBP and C9ORF72
fibroblasts in glycolitic conditions. Measurement of mitochondrial (MMP) by
flow cytometry analysis of TMRM-positive fibroblasts (4 healthy controls, 3
TARDBP and 4 C9ORF72), maintained in medium with 2 g/l glucose.
Median ± SEM, n = 3 different DIV; One-way ANOVA with Dunnett’s
multiple comparison test). Figure S4. Analysis of mitochondria mass
in mutant TARDBP and C9ORF72 fibroblasts in glycolitic conditions.
Measurement of mitochondrial mass (MM) by flow cytometry analysis
of Mitotracker green (MTG)-positive fibroblasts (4 healthy controls, 3
TARDBP and 4 C9ORF72), maintained in medium with 2 g/l glucose.
Median ± SEM, n = 3 different DIV; One-way ANOVA with Dunnett’s
multiple comparison test). Figure S5. TDP-43 sub-cellular localization in
C9ORF72 fibroblasts after 48 h in galactose medium. Representative
immunofluorescence images of TDP-43 (green) in primary fibroblasts from
healthy controls (four) and ALS/FTD patients carrying mutation in C9ORF72
gene (four), incubated with Mitotracker Red. Bar, 10 μm. Table S1. Clinical
features of healthy controls, TARDBP- and C9ORF72-mutated patients.
Table S2. Primer sequences and probes for Quantitative Real time
PCR. Table S3. Respiratory electron transport chain activity. Values
are expressed as nmol/min/mg protein and normalised with citrate
synthase activity. (PDF 609 kb)
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